Replimune Group, Inc. (REPL)

2.265 +0.40 (+21.77%) USD  |  NASDAQ  |  Apr 22, 16:00
2.28 +0.02 (+0.66%) After-Hours: 19:26
More

Replimune Group Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Phathom Pharmaceuticals, Inc. Upgrade
REGENXBIO, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade